KARLSRUHE, Germany – (BUSINESS WIRE) – joimax^® is continuing its year-over-year double digit growth. Over the past 9 months, joimax^® has grown more than 25% globally and in the United States alone, more than 35%. Among this major spurt, the market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery is launching a new endoscopic surgical system, TESSYS^® TransSAP.

“This allows for more extensive foraminal decompression and provides an optimal basis for transforaminal endoscopic fusion”

The company attributes strong growth to their popular workshop and educational program, which is now offered worldwide under the ESPINEA^® training academy. To keep momentum, joimax^® is releasing the TESSYS^® TransSAP — the fourth addition to the TESSYS^® family encompassing the standard TESSYS^® Std, TESSYS^® XT featuring longer reach instruments, and TESSYS^® Thx, the optimized version for the thoracic spine.

The system is based on the proven TESSYS^® method introduced in 2004. Since then, the technology has been enhanced and can be used for more complex indications, widening the spectrum of disease and vertebral level applications.

“The TransSAP method follows an adopted access path to the spine, directly targeting the Superior Articulating Process,” says Dr. Christoph Hofstetter, associate professor in the Department of Neurological Surgery at the University of Washington. “This allows for more extensive foraminal decompression and provides an optimal basis for transforaminal endoscopic fusion,” adds Dr. Ralf Wagner, a longstanding joimax^® ESPINEA^® Faculty orthopedic surgeon based in Frankfurt.

In addition, joimax^® provides a series of implants for fusion indications, such as the percutaneous pedicle screw system, Percusys^® Plus, and a family of 3D-printed titanium cages within the EndoLIF^® program. The EndoLIF^® suite of products consists of the static implants O/On-Cage, Delta-Cage and DoubleWedge-Cage. “There are plans to add a new fully-expandable cage, as well as a navigated solution for endoscopic disc preparation and implant positioning to provide a full endoscopic assisted fusion platform,” says Wolfgang Ries, CEO and founder of joimax^®.

All joimax^® implants can be safely inserted using the “Over-the-Wire” technique for precise implantation, making them ideal for endoscopically-assisted fusion procedures established and protected by joimax^®.

These new products have been exhibited at the following trade shows: SMISS in Las Vegas, CNS in San Francisco, and NASS in Chicago, and will be featured at EUROSPINE in Milan and at the German Spine Congress, DWG, in Berlin later this year.

Karlsruhe, Germany – February 27th, 2017 – joimax^® further ensures its market access in Asia. The German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery is expanding its presence and recently has obtained full product registration from the Thai Food & Drug Administration (FDA). joimax^® also has approvals in South Korea, China, Singapore, Indonesia, Hong Kong and Vietnam. For Malaysia, Taiwan and Japan, the certification for the product range is expected in 2017. “We are constantly pushing the registration process in Asia to extend the availability of joimax^® products. Thus, joimax^® is well prepared to further widen its market presence in Asia, demonstrating our commitment to the fastest growing region of the world,” states Wolfgang Ries, Founder and CEO of joimax^®.

For years, joimax^® has been working with the Korean Wooridul group, the world’s largest Specialized Spine Hospital Network. Starting in 2017, joimax^®, together with the Wooridul Hospital in Seoul, will offer International courses for Minimally Invasive Spinal Surgery (MISS). In a series of four courses, provided in basic and advanced level, the education of international spine surgeons is ensured. The first one, chaired by joimax^® faculty Dr. Sang-Ho Lee, South Korea, recently took place. The one-week training programs offer surgeons the opportunity to learn percutaneous endoscopic techniques and other minimally-invasive procedures with lectures, operation observation and hands-on-workshops. Since 2004, more than 600 spine surgeons and specialists from 41 countries have participated in these courses at Wooridul.

After the National Minimal Invasive Spinal Summit Forum, together with the 4^th joimax^® User Meeting in December, joimax^® China, headquartered in Chengdu, will celebrate its 10^th birthday in April 2017. On this occasion, numerous internationally well-known faculties will meet in Chongqing, China to share experience and expertise. Lectures and live surgeries are planned to be held in two hospitals and to be broadcasted via Internet.

Endoscopy in Pain Therapy

Focus on Facet Joint – Sacroiliac Joint – Peripheral nerves
New Endoscopic Approach

The aim of the Course of Endoscopy in Pain Therapy is to develop endoscopic techniques in the treatment of common diseases like Low Back Pain, Sacroileitis and Peripheral nerves pain. This course gives the participants an overview of endoscopic possibilities and new approaches in Pain Therapy.

The course is divided in two sessions, a frontal didactical part with an explanation of anatomy and physiopathology of facet joint pain, sacroliliac pain and peripheral nerves disturbs, and it is followed by a practice part with 2 / 3 surgical procedures performed by Dr. Meloncelli and his equipe with a direct explanation of surgical aspects.

At a glance:

One day meeting with live surgery
Rome, November 24, 2018, 9:30 – 17:00

Course director: Dr. Stefano Meloncelli
Secretary: Dr. Ignazio Urti
Faculty: Dr. Marco Divizia, Dr. Giorgio Germani

Location:
Casa di Cura „Valle Giulia“
Via Guiseppe de Notaris 2, Roma
www.clinicavallegiulia.it

Number of Participants: 10
Subscription: 600 Euro

Reservation and information:
Medical Training
phone number:+39 329 771 41 69
email: infomedicaltraining@gmail.com

sponsored by

Maximilian Ries

Ries took on the newly created role of Executive Vice President, Business Development and Operations at joimax^®. In this position, based in Germany, he will be responsible for scaling global operations to ensure joimax^® continues its exponential growth. Formerly the General Manager, for the past six of his 13-year tenure with joimax^®, Ries built out the United States and Latin American markets.

Tony Troncale

Troncale was promoted to General Manager; he was formerly Vice President of Marketing and Business Development at joimax^® Inc. Over the past two years, Troncale, in addition to increasing his responsibilities, successfully capitalized on the significant interest in endoscopic techniques to expand US sales operations. He joined joimax^® in 2021 bringing 20-years of experience in the spinal device industry where he served in sales and marketing leadership roles at Stryker, K2M, and Synthes Spine. Contributing to the global organization’s continuous strong sales growth was the launch of a new surgical access system, “Tessys^® Trans SAP” and the global expansion of the ESPINEA^® Education Academy.

Wolfgang Ries

“I am extremely pleased with our 2022 global performance and the significant interest in endoscopic spine surgery,” stated joimax^® Founder and CEO Wolfgang Ries. “With Max and Tony in their new roles, our market-leading endoscopic spine technologies, and our anticipated launch of two more new surgical access systems later in 2023, we are well positioned for another very successful year.”

Karlsruhe, Germany – April 11^th, 2017 – joimax^®, the German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery, just celebrated its 10 years’ birthday in China with an outstanding 3 days event in Chongqing. More than 900 surgeons out of 2,000 users in China only took part in live surgeries, workshops and a scientific program on endoscopic spinal technologies including MISS fusion techniques. Besides, joimax^® organized the presentation of its latest systems like the TESSYS^® ISeeU and iLESSYS^® Delta in product trainings as well as newest tools for endoscopic treatment in an exhibition hall. The program was supported by joimax^® Faculty Members from Europe, USA and other countries. In the course of the meeting a Chinese Faculty Team with 13 members was inaugurated by Wolfgang Ries, Founder and CEO of joimax^® and Qin-Guang You, President of joimax^® China. ”Due to the growing education and training needs in the Asian region the time has come to form a local team for this important market”, explains Wolfgang Ries. “It is a great honor to lead this team and to support the further growth of joimax^®”, says the head of the Faculty Team, Prof. Yue Zhou from the Third Military Medical University in Chongqing. He was awarded with the joimax^® Handshake Award in Gold for his exceptional commitment and the members of the group received the joimax^® Handshake Award in Silver.

After very satisfying growing sales figures in 2016 (31 % growth vs. 2015), joimax^® is proud to announce a jump in sales in the first quarter 2017. Consolidated figures show an increase of 60 % compared to the same period of last year. “This is a very encouraging development, showing the continuing expansion and growth of the group”, states Wolfgang Ries, Founder and CEO of joimax^®.

Irvine, CA – November 5, 2018 – joimax^®, the Germany-based market leader of technologies and training methods for full-endoscopic minimally-invasive spinal surgery, announces the move of its US headquarters to a new 26,000-square-foot facility in Irvine, California, beginning November 5, 2018.
“With the move to the new building, the steadily growing need for endoscopic procedures among patients and physician communities can now be efficiently met,” states Wolfgang Ries, Founder and CEO of the joimax^® Group. “Growth requires space — the continued demand in the US market creates a major opportunity which joimax^® Inc. is addressing with the expansion of its US organization.”

The new office is located at 140 Technology Drive, Suite 150 in the city of Irvine and includes a brand new training and education center. The center offers a demonstration and wet lab training room displaying all joimax^® systems and products, as well as a big audience room for didactics presentations. The first workshop will be held at the center on Nov 30^th – Dec 1st, 2018.

In addition, the new facility will handle all corporate and business functions. Over the next year, joimax® Inc. will add more clinical support, marketing, and sales personnel in order to face the fast growing demand for endoscopic spine procedures.

KARLSRUHE, Germany – (BUSINESS WIRE) – joimax^®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, launched its new iLESSYS^® Biportal Interlaminar Endoscopic Surgical System for the treatment of spinal disorders at the EUROSPINE 2023 Annual Meeting in Frankfurt and at the SMISS Annual Forum (Society for Minimally Invasive Spine Surgery) in Las Vegas, marking its global debut. This week, it will be presented at the NASS meeting (North American Spine Society) in Los Angeles.

The new instrument set, iLESSYS^® Biportal for unilateral biportal endoscopy (UBE), expands the wide range of joimax^® endoscopic offerings by separating the instrument working port from the endoscope, allowing for free relative movement between the two. The iLESSYS^® Biportal offers all instruments tailor-made for biportal spinal endoscopy, with:

• A special Triangulation Tool to simplify the access triangulation of two ports
• Biportal specific working tubes with inbuilt irrigation outflow control for precise water management
• Larger, more powerful tools for effective tissue ablation and resection

“This system is excellent and will allow me to perform the surgeries not only biportally but also bimanually,” stated Javier Quillo-Olvera, M.D., spinal neurosurgeon and an expert in biportal surgery at the Brain and Spine Care Group, Querétaro, Mexico. “It allows me to use the iLESSYS^® Pro working channel endoscope. I’m excited to use it with my patients.”

EUROSPINE attendees were impressed that this comprehensive system could be used as a biportal system and available for bimanual surgical procedures. Moreover, the iLESSYS^® played a key role during the expert talks, spurring debate about when to use the transforaminal (TESSYS®) and when to use the interlaminar (iLESSYS®) approach for a given spinal disease.

“The system will be part of the ESPINEA^® training and education program and will be fully implemented in the workshop courses by the end of the year,” commented Wolfgang Ries, CEO and founder of the joimax^® group. “We´ve already lined up a range of surgical faculty in Europe (Dr. Ralf Wagner, Dr. Maxime Challali, Dr. Raed Abohussein, Dr. Miguel Loureiro), in the Americas (Dr. Peter Derman, Dr. Meng Huang, Dr. Javier Quillo-Olvera) and in Asia (Prof. Si-Young Park, Dr. Junseok Bae) among others in each of these regions, with many more to follow.”

Irvine, CA – April 26, 2017 – joimax^®, the German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Endovapor^® 2 Multi Radio Frequency System.

The patented device generates electrical power for monopolar and bipolar cutting and coagulation of tissue structures in surgical operations. The joimax^® Endovapor^® 2 is an all-in-one generator with specially integrated programs for spinal surgery with interdisciplinary application. The device is equipped with two monopolar and two bipolar sockets and an easy and intuitive touchpad technology. With arc control for safe application and easy neutral electrode monitoring, it combines a variety of different electro-surgical modes and effects.

“After receiving the FDA clearance for the joimax^® Vaporflex^® and Legato^® electrosurgical probes in early  November 2016, this is another milestone in strengthening the joimax^® position as an expert in endoscopic minimally invasive spine surgery,” states Wolfgang Ries, Founder and CEO of joimax^®.

During the AANS, joimax^®  participated in the CME endoscopic cadaveric workshop with two stations and held a very successful US-expert meeting including topics such as training procedures, clinical Research and future technologies.

Karlsruhe, GER– February 8, 2019 – joimax^®, the Germany-based market leader of technologies and training methods for full-endoscopic minimally-invasive spinal surgery, is pleased to announce its expanded international market presence with new distribution partners in Brazil and Japan.
In Brazil, joimax^® is partnering with the privately-owned CT Group, which offers more than 20 years experience in the medical technology market. CT Group delivers a unique strategy and approach in the Brazilian market, focusing on the spine segment. The group is composed of 5 affiliated companies that provide innovative and high standard medical devices and equipment throughout the country.

“We are very happy to represent joimax^® and its complete endoscopic product portfolio in Brazil,” states Volnei Luiz Ortigara, Chairman of the Brazilian CT Group. “Together, we will ensure an outstanding market presence”.

Currently, there are 50 potential providers in Brazil who have been trained on the joimax^® methods and will be able to start offering joimax^® endoscopic procedures this spring. In Japan, joimax^® is partnering with United Biomech Japan, Inc., who will oversee distribution of the complete joimax^® product line countrywide. The official market launch will take place at the 48^th Annual Meeting of the Japanese Society for Spine Surgery and Related Research (JSSR), April 18 – 20, 2019 in Yokohama, Japan. The agreement coincides with the Japan-EU Free Trade Agreement (JEFTA) which came into effect February 1, 2019.
“This is the first time joimax^® will be involved with the Japanese market,” states Wolfgang Ries, Founder and CEO of the joimax^® Group. “We are excited to extend our global reach and offer superior medical products and training internationally.”

The presence in these two major markets is part of the overall growth strategy for joimax^® further positioning the company as a leader in the spine industry.

 

About Uber Ros S.p.A

Uber Ros S.p.A was founded in Rome in 1986 by Dr. Umberto Rosati and his son Giorgio. It is a Medical Devices Distribution Company active in all Italian territories. Uber Ros promotes and sells high-tech medical devices, mainly specialized in Orthopedics, Trauma Surgery, Neurosurgery, Spine, Maxillo-Facial, Head and Neck surgery (ENT-OTO), Wound Care and Vascular surgery. Uber Ros has a sales organization spread throughout Italy, providing customer service 24 hours on any day of the year. The Company collaborates with the world leading Research Centers, and is involved in the most advanced studies on bioengineering, promoting and supporting scientific research in high-tech emerging fields.